Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

NeuBase Therapeutics, Inc. (OHRP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Sep-30-21Sep-30-20Sep-30-19Sep-30-18Sep-30-17Sep-30-16Sep-30-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]0.00.00.00.01.20.149.90.0
            Revenue growth     -100.0%1636.7%-99.9%  
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.01.20.149.90.0
            Gross margin      100.0%100.0%100.0% 
Selling, general and administrative   [+]11.912.210.19.13.65.37.77.5
Research and development  21.411.56.93.44.317.416.58.8
Equity in earnings  -0.4-0.2-0.3    0.1
Other operating expenses   2.9 13.0  1.2-2.6
EBITDA   [+]-33.0-26.4-17.1-25.4-6.7-22.624.6-13.5
            EBITDA margin      -547.3%-31960.6%49.3% 
Depreciation  0.80.40.30.00.00.00.10.0
EBITA  -33.7-26.8-17.3-25.4-6.7-22.724.5-13.6
            EBITA margin      -548.1%-32024.3%49.2% 
Amortization of intangibles     0.11.11.11.11.1
EBIT   [+]-33.7-26.8-17.3-25.5-7.8-23.823.4-14.7
            EBIT margin      -638.8%-33608.1%46.9% 
Non-recurring items   [+]    6.1 -1.23.0
Interest income, net   [+]0.10.00.0-0.10.10.00.00.0
Other income (expense), net   [+]-0.21.40.0-0.5-12.6-23.8-50.42.5
Pre-tax income  -33.8-25.4-17.4-26.1-26.5-47.6-25.8-15.2
Income taxes  0.00.00.00.0-13.2-23.80.00.0
            Tax rate  0.0%0.0%0.0%0.0%50.0%50.0%0.0%0.0%
Net income  -33.8-25.4-17.4-26.1-13.2-23.8-25.8-15.2
            Net margin      -1077.2%-33651.8%-51.6% 
   
Basic EPS   [+]($1.04)($0.93)($0.89)($3.16)($0.23)($0.53)($0.82)($0.54)
Diluted EPS   [+]($1.04)($0.93)($0.89)($3.16)($0.23)($0.53)($0.82)($0.54)
   
Shares outstanding (basic)   [+]32.527.319.68.356.444.831.328.4
Shares outstanding (diluted)   [+]32.527.319.68.356.444.831.328.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy